QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
NASDAQ:QNCX

Quince Therapeutics - QNCX News Today

$1.56
+0.02 (+1.30%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.53
▼
$1.58
50-Day Range
$0.76
▼
$1.55
52-Week Range
$0.54
▼
$6.80
Volume
344,058 shs
Average Volume
2.29 million shs
Market Capitalization
$56.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Quince Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNCX and its competitors with MarketBeat's FREE daily newsletter.


QNCX Media Mentions By Week

QNCX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

QNCX
News Sentiment
▼
1.89

0.60
▲
Average
Medical
News Sentiment

QNCX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

QNCX Articles
This Week
▼
0

0
▲
QNCX Articles
Average Week

SourceHeadline
businesswire.com logoQuince Therapeutics Confirms Receipt of Unsolicited Acquisition Offer from Echo Lake Capital
businesswire.com - March 22 at 5:12 AM
benzinga.com logoQuince Therapeutics shares are trading higher after Echo Lake Capital offered to acquire the company for $1.60 per share in cash.
benzinga.com - March 21 at 12:45 PM
msn.com logoQuince stock surges ~50% on acquisition offer from Echo Lake Capital
msn.com - March 21 at 12:45 PM
finance.yahoo.com logoEcho Lake Capital Offers to Acquire Quince Therapeutics, Inc.
finance.yahoo.com - March 21 at 12:45 PM
msn.com logoQuince expects ~$11M annual capital and operating expenditures in 2023
msn.com - January 30 at 5:53 PM
finance.yahoo.com logoQuince Therapeutics Provides Pipeline Update and Business Outlook for 2023
finance.yahoo.com - January 30 at 5:53 PM
bizjournals.com logoCasey Lynch and her Cortexyme team regroup at Lighthouse for another shot at Alzheimer's
bizjournals.com - January 27 at 7:56 PM
investorplace.com logoWhy Is Quince Therapeutics (NASDAQ:QNCX) Stock Up 53% Today?
investorplace.com - January 27 at 11:02 AM
finance.yahoo.com logoQuince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals
finance.yahoo.com - January 27 at 8:16 AM
barrons.com logoQuince Therapeutics Inc.
barrons.com - January 15 at 2:20 PM
finance.yahoo.com logoWe Think Quince Therapeutics (NASDAQ:QNCX) Needs To Drive Business Growth Carefully
finance.yahoo.com - November 21 at 11:55 AM
investing.com logoQuince Therapeutics Inc (QNCX)
investing.com - October 1 at 1:11 PM
finance.yahoo.com logoQuince Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022
finance.yahoo.com - September 26 at 8:21 AM
finance.yahoo.com logoQuince Therapeutics to Present at Upcoming Scientific Meetings
finance.yahoo.com - September 26 at 8:21 AM
finance.yahoo.com logoQuince Therapeutics Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta Fractures
finance.yahoo.com - September 26 at 8:21 AM
finance.yahoo.com logoQuince Therapeutics Presents Preclinical Data at ASBMR 2022 Demonstrating Application of Bone-targeting Platform for Spinal Fusion and Bone Cancer Indications
finance.yahoo.com - September 26 at 8:21 AM
finance.yahoo.com logoQuince Therapeutics Presents Preclinical Data at MHSRS 2022 Demonstrating Preclinical Efficacy of Bone-targeting Platform for Traumatic Bone Injury
finance.yahoo.com - September 26 at 8:21 AM
Get Quince Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNCX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:QNCX) was last updated on 3/31/2023 by MarketBeat.com Staff